chrX-40581020-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_005765.3(ATP6AP2):c.-46C>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000464 in 1,160,049 control chromosomes in the GnomAD database, including 1 homozygotes. There are 145 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0024 ( 0 hom., 72 hem., cov: 25)
Exomes 𝑓: 0.00025 ( 1 hom. 73 hem. )
Consequence
ATP6AP2
NM_005765.3 5_prime_UTR
NM_005765.3 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.977
Genes affected
ATP6AP2 (HGNC:18305): (ATPase H+ transporting accessory protein 2) This gene encodes a protein that is associated with adenosine triphosphatases (ATPases). Proton-translocating ATPases have fundamental roles in energy conservation, secondary active transport, acidification of intracellular compartments, and cellular pH homeostasis. There are three classes of ATPases- F, P, and V. The vacuolar (V-type) ATPases have a transmembrane proton-conducting sector and an extramembrane catalytic sector. The encoded protein has been found associated with the transmembrane sector of the V-type ATPases. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant X-40581020-C-A is Benign according to our data. Variant chrX-40581020-C-A is described in ClinVar as [Benign]. Clinvar id is 204913.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Hemizygotes in GnomAd4 at 72 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ATP6AP2 | NM_005765.3 | c.-46C>A | 5_prime_UTR_variant | 1/9 | ENST00000636580.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ATP6AP2 | ENST00000636580.2 | c.-46C>A | 5_prime_UTR_variant | 1/9 | 1 | NM_005765.3 | P3 |
Frequencies
GnomAD3 genomes AF: 0.00245 AC: 278AN: 113286Hom.: 0 Cov.: 25 AF XY: 0.00203 AC XY: 72AN XY: 35436
GnomAD3 genomes
AF:
AC:
278
AN:
113286
Hom.:
Cov.:
25
AF XY:
AC XY:
72
AN XY:
35436
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000534 AC: 55AN: 103015Hom.: 0 AF XY: 0.000543 AC XY: 20AN XY: 36835
GnomAD3 exomes
AF:
AC:
55
AN:
103015
Hom.:
AF XY:
AC XY:
20
AN XY:
36835
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000249 AC: 261AN: 1046714Hom.: 1 Cov.: 29 AF XY: 0.000215 AC XY: 73AN XY: 339844
GnomAD4 exome
AF:
AC:
261
AN:
1046714
Hom.:
Cov.:
29
AF XY:
AC XY:
73
AN XY:
339844
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00244 AC: 277AN: 113335Hom.: 0 Cov.: 25 AF XY: 0.00203 AC XY: 72AN XY: 35495
GnomAD4 genome
AF:
AC:
277
AN:
113335
Hom.:
Cov.:
25
AF XY:
AC XY:
72
AN XY:
35495
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 23, 2014 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at